Cevimeline Hydrochloride Capsule
Product Images NDC 72789-457

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cevimeline Hydrochloride (NDC 72789-457). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789457 Label (72789457)

This text provides information about a medication in the form of capsules containing 30 mg of cevimeline hydrochloride. The product is marketed and packaged by PD-Rx Pharmaceuticals, Inc. It should be stored at a temperature between 20° to 25°C (68° to 77°F). The manufacturer is Rubicon Research Private Limited in Ambernath, India. The prescribing information and details about the product, such as expiration date and lot number, are included in the text.*

FDA Label Image

The Structural Formula For Cevimeline Is Cis -2’-methylspiro{1-azabicyclo [2.2.2] Octane-3, 5’-[1,3] Oxathiolane} Hydrochloride, Hydrate (2:1). Its Empirical Formula Is C10h17nos.hcl. (Cevimeline Hydrochloride Capsules Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.